CAS 862366-25-4

Imatinib-d8 Hydrochloride

Produit contrôlé

CAS : 862366-25-4

Formule : C₂₉H₂₃D₈N₇O·xHCl

Couleur et forme : Neat

Masse moléculaire : 501.65 + x(36.46)

Ref: TR-I267983

Imatinib Hydrochloride

CAS : 862366-25-4

Applications Imatinib Hydrochloride is a tyrosine kinase inhibitor. It is a COVID19-related research product.
References Schindler, T., et al.: Science, 289, 1938 (2000); Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001)

Formule : C₂₉H₃₁N₇O·ClH

Couleur et forme : Neat

Masse moléculaire : 530.06

Ref: TR-I267980

Imatinib hydrochloride

CAS : 862366-25-4

Imatinib is a hydrated, desmethyl imatinib that belongs to the group of anhydrase inhibitors. It is used in the treatment of cardiovascular diseases such as hypertension. Imatinib has been shown to inhibit adenosine receptor antagonists and has been found to be effective against acylation reactions in vitro. Imatinib hydrochloride is soluble in water, so it can be given intravenously or orally. The reaction time for imatinib hydrochloride is two hours at 25 degrees Celsius and six hours at 37 degrees Celsius.

Formule : C₂₉H₃₂ClN₇O

Degré de pureté : Min. 95%

Masse moléculaire : 530.1 g/mol

Ref: 3D-MJB36625

Imatinib hydrochloride

CAS : 862366-25-4

Imatinib: treats CML/GISTs, inhibits v-Abl/c-Kit/PDGFR (IC50: 0.6/0.1/0.1 μM).

Formule : C₂₉H₃₂ClN₇O

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 530.06

Ref: TM-T22859